Open AccessPossible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai
Author(s) -
Zarir Udwadia,
Jai Mullerpattan,
Kushal D. Shah,
Camilla Rodrigues
Publication year - 2016
Publication title -
lung india
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 25
eISSN - 0974-598X
pISSN - 0970-2113
DOI - 10.4103/0970-2113.180800
Subject(s) - medicine , regimen , tuberculosis , multiple drug resistance , drug resistance , drug , pharmacology , pathology , microbiology and biotechnology , biology
Treatment of multidrug-resistant tuberculosis (MDR-TB) in the Programmatic Management of Drug-resistant TB program involves a standard regimen with a 6-month intensive phase and an 18-month continuation phase. However, the local drug resistance patterns in high MDR regions such as Mumbai may not be adequately reflected in the design of the regimen for that particular area.